Brought to you by:
ROADSTER 3 provides key evidence that ‘goes beyond registry data’ on TCAR-related stroke rates
Thirty-day results from the ROADSTER 3 study have demonstrated that transcarotid artery revascularization (TCAR) is a safe and effective approach in patients who are deemed to be standard risk for experiencing adverse events related to carotid endarterectomy (CEA). These findings…
Penumbra launches Element vascular access system for VTE
Penumbra recently announced the launch of its Element vascular access system. This is the first laser-cut hypotube sheath designed for venous thromboembolism (VTE), the company shares in a press release. Penumbra notes that Element is compatible with the Lightning Flash…
US ARC uncovers ‘dramatic’ decrease in use of prophylactic spinal drains at same time as spinal cord ischemia steeply declines
Despite a “dramatic” decrease in the use of prophylactic cerebrospinal fluid drains (CSFDs) for the prevention of spinal cord ischemia (SCI) in patients undergoing fenestrated and branched endovascular aortic repair (F/BEVAR), the rate of SCI has tracked a similarly dramatic…
Vascular Verification Program verifies first community hospital
Intermountain Health St. Mary’s Regional Hospital in Grand Junction Colorado was awarded ACS/SVS Vascular Verification Program (Vascular-VP) designation on Nov. 19, 2024. By achieving this prestigious status, the medical center demonstrated its commitment to delivering high quality treatment for patients…
Study highlights declining venous stent patency rates after one year
A systematic review and meta-analysis of over 1,500 venous stenting procedures—said to be the first study on this topic to date—has highlighted an 18% drop in primary patency rates after one-year follow-up with declining rates beyond 12 months. As a…
Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds
Pending the results of several trials and “iterative changes” to device design, bioabsorbable scaffolds are set to change the treatment paradigm for lower extremity peripheral arterial disease (PAD) within the next decade. So concluded Eric Secemsky (Beth Israel Deaconess Medical…
Deadline for inaugural SVS visiting professorship to advance young surgeons’ careers nears
The Society for Vascular Surgery’s (SVS) Young Surgeon Section (YSS) will close applications for its inaugural visiting professorship on Jan. 31. This scholarship program will provide mentorship opportunities, foster professional development and introduce young vascular surgeons to diverse clinical and…
Cagent Vascular initiates the Serranator POINT FORCE observational registry
Cagent Vascular has announced the start of the POINT FORCE registry, a postmarket clinical follow-up study of the Serranator percutaneous transluminal angioplasty (PTA) serration balloon catheter. This prospective, multicentre, single-arm study will enrol a minimum of 500 patients at up…
Gore announces first commercial implant of Excluder conformable AAA endoprosthesis with Active Control system in Canada
Gore recently announced the first commercial use of its Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada. The news coincides with Health Canada approval of the device for the treatment of AAA patients with aortic…
Tracci assumes presidency of Southern Vascular
Margaret (Megan) Tracci, MD, has become the first-ever woman president of the Southern Association for Vascular Surgery (SAVS). The University of Virginia professor of surgery assumed the role at the close of the 2025 SAVS annual meeting in St. Thomas,…